MARK2 and neurodegenerative disease: Among the hundreds of serine-threonine protein kinases, only a small number have been seriously implicated in the pathogenesis of neurodegenerative diseases and within this group, less than a dozen common kinases have been described to play a key role in diverse neurodegenerative disease with distinct etiologies.